Hikma Pharmaceutical | HIK - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Almirall EUR 214.79M 0 2025-12
argenx SE USD 62.54M 2.74M 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Autolus Therapeutics Ltd USD 266.14M 0 2026-03
Bayer EUR 982.42M 0 2026-06
Fresenius EUR 563.24M 0 2026-06
Genmab DKK 61.44M 181K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
GRIFOLS EUR 680.58M 6K 2026-06
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lakefront Biotherapeutics EUR 65.66M 242K 2026-06
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2026-06
Orion EUR 140.87M 0 2026-06
Recordati EUR 204.81M 1.38M 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
UCB EUR 190.36M 365.15K 2025-12